Table 1

Mutations found in patients with persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI) within the SUR1 and KIR6.2 genes

Mutation
designation
Exon or
intron
Codon predicted
change
Domain Restriction
site change
Refs
SUR1
c.221G > AExon 2R74QTmPstI 41
Exon 3A116PTmBbv1 28
c.375C > GExon 3H125QDdel 41
Exon 4V187DTm 42
c.563A > GExon 4N188STmTspRI 41
Exon 5679 ins 18 nt 28
Exon 5731 del a 28
Exon 5L226 ins 5aa 28
Exon 5R248X 28
c.949delCExon 6317fs/terTmBsp1286I 41
c.1216A > GExon 8N406DXcmI 41
Exon 8C418RBglII 28
1260 ins31 basesExon 8Insertion of 31 bp 28
Exon 10L508PMspA1, MspBII 28
c.1630 + 1G > TIntron 10Aberrant splicingBsrI 41
c.1671–20A > GIntron 11Aberrant splicingSpeI 43
c.1773C > GExon 12F591LTmBsoFI 41
Exon 13R620CXhoII 28
Exon 13H627X 28
c. 1885 del CExon 13 28
c.1893delTExon 13631fs/terBstNI 41
c.2117–1G > AIntron 15Aberrant splicingNBD-1PstI 41
c.2147G > TExon 16G716VNBD-1BbvI 43
c.2291–1G > AIntron 18Aberrant splicingNBD-1BstNI 43
Exon 21R836XNBD-1Bsr1 44
Exon 21R842GNBD-1Glaseret al, 1999
c.2860C > TExon 24Q954XBstNI 41
Exon 24S957F 28
c.3416C > TExon 28T1139MNiaIII 41
c.3651–1G > TIntron 29 28
c.3644G > AExon 29R1215QStu1 41
c.3992–9G > AIntron 32Aberrant splicingNciI 43, 45
c.3992–3C > GIntron 32Aberrant splicingAvaI 41
Exon 33K1337NGlaser et al, 1999
Exon 33W1338XBstx1 29
c.4058G > CExon 33R1352PhHa1 46
Exon 33V1360MBsrFI 28
c. del4138 CGACNBD-2 47
c. 4144 (complex)NBD-2 28
c.4135G > CExon 34G1379RNBD-2EagI 41
c.4144G > AExon 34G1382SNBD-2Bg1I 41
Exon 34S1387FNBD-2Mnl1 28
c.4162delTTCExon 34F1388delNBD-2BseRI 45
c.4181G > AExon 34R1394HNBD-2BflM1 41
Exon 35R1419CNBD-2Hha1 28
c.4261C > TExon 35R1421CNBD-2NiaIII 28, 46
c.4310G > AExon 35R1437Q(23)X, aberrant  splicingNBD-2MspI 28, 43, 48,49
Exon 36A1457TNBD-2 42
NDExon 37G1479RNBD-2AciI 28, 50
Exon 374415–13G > ANci1 28
Exon 37A1493TGlaseret al, 1999
c.4480 C> TExon 37R1494WNBD-2Sma1 28, 46
Exon 37R1494QNBD-2Glaser et al, 1999
c.4525ins 4 basesExon 37Insertion of AlaSer after  codon 1508NBD-2PvuII 41
Exon 37F1506KNBD-2 51
Exon 38E1507KNBD-2Mnl1 28
Exon 39L1544P 28
KIR6.2
c.649T > CExon 1L147PPvuI, Ava1 50
Exon 1W 91 RAciI 29
c.39C > AExon 1T12XBsaAI 50
  • Tm, putative transmembrane domain (according to Swiss-ProtQ09428); NBD, nucleotide binding domain; ND, no data available; M2 region, one of two potential transmembrane spanning domains; nt nucleotide; bp base pairs.